NCT06825910 LMA I-Gel Versus LMA Protector During Minor Urological Procedures Under General Anesthesia in Adult Patients
| NCT ID | NCT06825910 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nikolopoulou Maria Zozefin |
| Condition | Airway Management |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-02-01 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-02-01 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This will be a randomized comparative study comparing the two supraglottic devices i-gel and Protector, intraoperatively, during minor urological procedures under general anesthesia in adult patient.
Eligibility Criteria
Inclusion Criteria: * ASA I-II * Patients older than 18 years * Procedures in supine and lithotomy position Exclusion Criteria: * Tumors or anatomical anomalies of the upper airway * Known history of difficult intubation * Limited mouth opening less than 2cm * Decreased compliance of the lungs or the thoracic cage * Need of mechanical ventilation after the surgery
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06825910 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Airway Management. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06825910 currently recruiting?
Yes, NCT06825910 is actively recruiting participants. Contact the research team at mz.nikolopoulou@gmail.com for enrollment information.
Where is the NCT06825910 trial being conducted?
This trial is being conducted at Athens, Greece, Athens, Greece.
Who is sponsoring the NCT06825910 clinical trial?
NCT06825910 is sponsored by Nikolopoulou Maria Zozefin. The trial plans to enroll 100 participants.